Abeer H. Elmaidomya,
Rabab Mohammeda,
Asmaa I. Owisa,
Mona H. Hettab,
Asmaa M. AboulMagdc,
Abu Bakar Siddiqued,
Usama Ramadan Abdelmohsenef,
Mostafa E. Ratebag,
Khalid A. El Sayedd and
Hossam M. Hassan*a
aDepartment of Pharmacognosy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt. E-mail: hossam.abdelazeem@pharm.bsu.edu.eg
bDepartment of Pharmacognosy, Faculty of Pharmacy, Fayoum University, Fayoum 63514, Egypt
cDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Nahda University, Beni-Suef 62514, Egypt
dSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71201, USA
eDepartment of Pharmacognosy, Faculty of Pharmacy, Minia University, Minia 61519, Egypt
fDepartment of Pharmacognosy, Faculty of Pharmacy, Deraya University, Minia 61111, Egypt
gSchool of Computing, Engineering and Physical Sciences, University of the West of Scotland, PA1 2BE Paisley, UK
First published on 22nd January 2021
Correction for ‘Triple-negative breast cancer suppressive activities, antioxidants and pharmacophore model of new acylated rhamnopyranoses from Premna odorata’ by Abeer H. Elmaidomy et al., RSC Adv., 2020, 10, 10584–10598. DOI: 10.1039/D0RA01697G
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2021 |